Archive for the ‘Business’ Category
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]
In: Business, El-Hibri, Financial Performance, Fuad El-Hibri, Healthcare Conference, Investors · Tagged with: Business, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Management, Webcast
Emergent BioSolutions Reports Financial Results for First Quarter 2011
ROCKVILLE, Md., May 05, 2011 (BUSINESS WIRE) — Emergent BioSolutionsInc. (NYSE: EBS) announced its financial results for the first quarter ended March 31, 2011.
For 1Q 2011, total revenues were $18.5 million as compared to $46.8 million in 2010. In addition, for 1Q 2011 the company recorded a net loss of $21.4 million, or $0.61 per [...]
In: BioDefense, Biothrax, Business, Chief Executive Officer, Chief financial officer, Revenue · Tagged with: BARDA, Biothrax, Emergent BioSolutions, Fuad El-Hibri, Research and development, Revenue
Emergent BioSolutions Reports Financial Results for Full Year 2010
2010 revenues of $286.2 million
2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability
2010 cash, investments and accounts receivable balance of $210.4 million
2011 forecast reaffirmed: total revenues of $320 to $340 million and net income of $35 to $45 million
Emergent BioSolutions Inc. (NYSE: EBS) announced on 10 March its [...]
In: Board of directors, Business, Chief Executive Officer, Emergent Bioslutions, Financial Results, Fuad El-Hibri · Tagged with: Anthrax vaccines, Biothrax, Business, Chief financial officer, Emergent BioSolutions, Financial Results
Fuad El-Hibri Recognized by Vilcek Foundation
The Vilcek Foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The Foundation was established with the aim of raising public awareness around immigrants’ contributions to the sciences, arts, and culture in the United States. The Foundation’s mission was inspired [...]
In: Business, Chief Executive Officer, El-Hibri Peace Education Prize, Emergent Bioslutions, Food and Drug Administration, Fuad, Fuad El-Hibri, Peace Education, Research and development, Yale university · Tagged with: El-Hibri Charitable Foundation, El-Hibri Peace Education Prize, Fuad El-Hibri, Humanitarian aid, United States, vilcek, vileck foundation, Yale
Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010
ROCKVILLE, Md., Oct 13, 2010 — Emergent BioSolutions Inc. (NYSE: EBS) announced today it will report financial results for third quarter 2010 on Thursday November 4, 2010, after market close. Company management will host a conference call at 5:00 pm Eastern on November 4, 2010 to discuss the financial results for [...]
In: Anthrax vaccines, Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri · Tagged with: Anthrax vaccines, Chief executive officer, Conference call, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri
Fuad El-Hibri and The National Health Museum
The National Health Museum (NHM) is a science-based institution devoted to educating and inspiring Americans to live healthier lives. With an on site museum planned in Atlanta, and a web-based cyber museum, NHM is committed to bringing health science to life with exhibits, programs, and teaching strategies [...]
In: Atlanta, Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, National Health Museum, Research and development · Tagged with: Atlanta, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, National Health Museum, United States
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
ROCKVILLE, Md., Jul 14, 2010
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale [...]
In: Business, Chief Executive Officer, Emergent Bioslutions, Food and Drug Administration · Tagged with: Anthrax vaccines, Biothrax, Emergent BioSolutions, Food and Drug Administration, Infectious disease, US government
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
The Jefferies & Company 2010 Global Life Sciences Conference
New [...]
In: Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare Conference · Tagged with: Business, Emergent Biosolutions Inc, Fuad El-Hibri, Healthcare Conference, Jefferies & Company, United States, Webcast
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
In: Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, United States · Tagged with: Business, Emergent BioSolutions, Fuad El-Hibri, Maryland